SUNITINIB VIATRIS 50 mg, gélule — 28 plaquette(s) aluminium OPA : polyamide orienté PVC de 1 gélule(s)
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930175637 -
CIP7
3017563 -
CIS
65674790
What the source publishes
- Holder
- VIATRIS SANTE
- Active ingredients
- SUNITINIB
- Form
- gélule
- Package
- 28 plaquette(s) aluminium OPA : polyamide orienté PVC de 1 gélule(s)
- Routes
- orale
- Administrative status
- authorised
- Supply regime
- médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2019-03-18
- Prescription
- Prescription or restricted
Names this record is found by
- SUNITINIB VIATRIS 50 mg, gélule — 28 plaquette(s) aluminium OPA : polyamide orienté PVC de 1 gélule(s)
- SUNITINIB VIATRIS 50 mg, gélule
- SUNITINIB
Complete source data
{
"cis": "65674790",
"cip7": "3017563",
"form": "gélule",
"name": "SUNITINIB VIATRIS 50 mg, gélule — 28 plaquette(s) aluminium OPA : polyamide orienté PVC de 1 gélule(s)",
"cip13": "3400930175637",
"holder": "VIATRIS SANTE",
"routes": [
"orale"
],
"holders": [
"VIATRIS SANTE"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": "1823.89",
"authorisedOn": "2019-03-18",
"compositions": [
{
"name": "SUNITINIB",
"nature": "SA",
"strength": "50 mg",
"linkageNumber": "1",
"substanceCode": "29335",
"dosageReference": "une gélule",
"pharmaceuticalElement": "gélule"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": "médicament nécessitant une surveillance particulière pendant le traitement ; prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE ; prescription réservée aux spécialistes et services HEMATOLOGIE ; prescription hospitalière ; liste I ; prescription réservée aux médecins compétents en CANCEROLOGIE",
"dispensingFee": "1.02",
"medicinePrice": "1822.87",
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "SUNITINIB VIATRIS 50 mg, gélule",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-11-20",
"CIS_CIP_bdpm": "2026-11-20",
"CIS_CPD_bdpm": "2026-11-20",
"CIS_COMPO_bdpm": "2026-11-20"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "28 plaquette(s) aluminium OPA : polyamide orienté PVC de 1 gélule(s)",
"patientEligibility": "not-assessed",
"reimbursementRates": [
"100%"
],
"marketingDeclaredOn": "2022-01-24",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "prescription-or-restricted",
"activeIngredientNames": [
"SUNITINIB"
],
"authorisationProcedure": "Procédure décentralisée",
"prescriptionConditions": [
"médicament nécessitant une surveillance particulière pendant le traitement",
"prescription réservée aux spécialistes et services ONCOLOGIE MEDICALE",
"prescription réservée aux spécialistes et services HEMATOLOGIE",
"prescription hospitalière",
"liste I",
"prescription réservée aux médecins compétents en CANCEROLOGIE"
],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": null,
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930175637"